Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Waddington, Simon N ^a   Tam, Frederick W K ^b   Cook, H Terence ^a   Cattell, Victoria ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adenosine 3',5' cyclic monophosphate; Glomerulonephritis; Interleukin 4; L arginine; Macrophages; N(G) hydroxy L arginine; Nitric oxide

Indexed keywords

ARGINASE; CYCLIC AMP; INTERLEUKIN 4; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SUBSTRATE; GLOMERULONEPHRITIS; MACROPHAGE ACTIVATION; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; UREA CYCLE;

EID: 0031895498     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.3.f473     Document Type: Article

References (57)

1. Albina, J. E., C. D. Mills, W. L. Henry, and M. D. Caldwell. Regulation of macrophage physiology by L-arginine: role of oxidative L-arginine deiminase pathway. J. Immunol. 143: 3641-3646, 1989.
2. Albina, J. E., C. D. Mills, W. L. Henry, and M. D. Caldwell. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144: 3877-3880, 1990.
3. Benninghoff, B., W. Dröge, and V. Lehmann. The lipopolysaccharide-induced stimulation of peritoneal macrophages involves at least two pathways. Eur. J. Biochem. 179: 589-594, 1988.
4. Bogdan, C., Y. Vodovotz, J. Paik, Q.-W. Xie, and C. Nathan. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukoc. Biol. 55: 227-233, 1994.
5. ω-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem. Biophys. Res. Commun. 203: 1614-1621, 1994.
6. Boucher, J.-L., A. Genet, S. Vadon, M. Delaforge, Y. Henry, and D. Mansuy. Cytochrome P450 catalyses the oxidation of Nw-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline. Biochem. Biophys. Res. Commun. 187: 880-886, 1992.
7. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J.-P. Moulinoux, and L. Baud. Transforming growth factor beta stimulates arginase activity in macrophages. J. Immunol. 155: 2077-2084, 1995.
8. G-hydroxy-L-arginine during high-output NO production. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1988-H1998, 1996.
9. Byrne, C. R., P. J. Hanson, and B. J. R. Whittle. Metabolism of arginine to citrulline by rat gastric mucosal cells (Abstract). Biochem. Soc. Trans. 24: 480S, 1996.
10. Cattell, V., T. Cook, and S. Moncada. Glomeruli synthesise nitrite in experimental nephrotoxic nephritis. Kidney Int. 38: 1050-1060, 1990.
11. Cattell, V., P. Largen, E. De Heer, and T. Cook. Glomeruli synthesize nitrite in active Heymann nephritis: the source is infiltrating macrophages. Kidney Int. 40: 847-851, 1991.
12. Cattell, V., E. Lianos, P. Largen, and T. Cook. Glomerular NO synthase activity in mesangial cell immune injury. Exp. Nephrol. 1: 36-40, 1993.
13. Cook, H. T., and V. Cattell. Role of nitric oxide in immune-mediated diseases. Clin. Sci. (Colch.) 91: 375-384, 1996.
14. Cook, H. T., V. Cattell, J. Smith, J. A. Salmon, and S. Moncada. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat. Clin. Nephrol. 26: 195-202, 1986.
15. Cook, H. T., H. Ebrahim, A. S. Jansen, G. R. Foster, P. Largen, and V. Cattell. Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat. Clin. Exp. Immunol. 97: 315-320, 1994.
16. Cook, H. T., A. Jansen, S. Lewis, P. Largen, M. O'Donnell, D. Reaveley, and V. Cattell. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F646-F653, 1994.
17. Cook, H. T., and R. Sullivan. Glomerular nitrite synthesis in In situ immune complex glomerulonephritis in the rat. Am. J. Pathol. 139: 1047-1052, 1991.
18. Corraliza, I. M., G. Soler, K. Eichmann, and M. Modolell. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10, PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206: 667-73, 1995.
19. Cunningham, J. M., J. G. Mabley, and I. C. Green. Regulation of RINm5F cell arginase by nitric oxide synthase reaction products (Abstract). Diabetologia 39: S393, 1996.
20. Currie, G. A. Activated macrophages kill tumour cells by releasing arginase. Nature 273: 758-759, 1978.
21. Currie, G. A., L. Gyure, and L. Cifuentes. Microenvironmental arginine depletion by macrophages in vivo. Br. J. Cancer 39: 613-620, 1979.
22. Daghigh, F., J. M. Fukuto, and D. E. Ash. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, N-hydroxyarginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun. 202: 174-180, 1994.
23. Gotoh, T., T. Sonoki, A. Nagasaki, K. Terada, M. Takiguchi, and M. Mori. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395: 119-122, 1996.
24. Hecker, M., H. Nematholahi, C. Hey, R. Busse, and K. Racké. Inhibition of arginase by N-hydroxyl-L-arginine in alveolar macrophages: implications for the utilisation of L-arginine for nitric oxide synthesis. FEBS Lett. 359: 251-254, 1995.
25. G-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. Eur. J. Pharmacol. 275: R1-R3, 1995.
26. Herzfeld, A., and S. M. Raper. The heterogeneity of arginases in rat tissues. Biochem. J. 153: 469-478, 1976.
27. ω-OH-D,L-indospicine, a potent and selective inhibitor of arginase in rat and rabbit alveolar macrophages (AMF) can promote utilisation of L-arginine by nitric oxide synthase (NOS). Br. J. Pharmacol. 120: 1P-385P, 1997.
28. Hey, C., I. Wessler, and K. Racke. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn Schmiedebergs Arch. Pharmacol. 351: 651-659, 1995.
29. Jansen, A., S. Lewis, V. Cattell, and H. T. Cook. Arginase is a major pathway of arginine metabolism in nephritic glomeruli. Kidney Int. 42: 1107-1112, 1992.
30. Katoh, T., F. G. Lakkis, N. Makita, and K. F. Badr. Coregulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. Kidney Int. 46: 341-349, 1994.
31. Kaysen, G. A., and H. J. Strecker. Purification and properties of arginase of rat kidney. Biochem. J. 133: 779-788, 1973.
32. Ketteler, M., N. Ikegaya, D. K. Brees, W. A. Border, and N. A. Noble. L-arginine metabolism in immune-mediated glomerulonephritis. Am. J. Kidney Dis. 28: 878-887, 1996.
33. Liew, F. Y., Y. Li, A. Severn, S. Millott, J. Schmidt, M. Salter, and S. Moncada. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21: 2489-2494, 1991.
34. McKnight, A. J., and B. J. Classon. Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4. Immunology 75: 286-292, 1992.
35. Meyer, J., N. Richter, and M. Hecker. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal. Biochem. 247: 11-16, 1997.
36. Modolell, M., I. M. Corraliza, F. Link, G. Soler, and K. Eichman. Reciprocal regulation of the nitric oxide synthase/ arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines. Eur. J. Immunol. 25: 1101-1104, 1995.
37. Nakazoto, Y., H. Okada, A. Sato, Y. Iwaita, T. Hayashida, M. Hayashi, H. Suzuki, and T. Saruta. Interleukin 4 downregulates cell growth and prostaglandin release of human mesangial cells. Biochem. Biophys. Res. Commun. 197: 486-93, 1993.
38. Nakazoto, Y., H. Okada, S. Tajima, and T. Hayashida. Interleukin-4 modulates collagen synthesis in a type-specific manner. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F447-F453, 1996.
39. Nebes, V. L., and S. M. Morris. Regulation of messenger ribonucleic acid levels for five urea cycle enzymes in cultured rat hepatocytes. Requirements for cyclic adenosine monophosphate, glucocorticoids, and ongoing protein synthesis. Mol. Endocrinol. 2: 444-451, 1988.
40. Nitsch, D. D., N. Ghilardi, H. Mühl, C. Nitsch, B. Brüne, and J. Pfeilschifter. Apoptosis and expression of inducible nitric oxide synthase are mututally exclusive in renal mesangial cells. Am. J. Pathol. 150: 889-900, 1997.
41. Okada, H., K. Konishi, Y. Nakazoto, Y. Kanno, H. Suzuki, H. Sakaguchi, and T. Saruta. Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am. J. Kidney Dis. 23: 242-246, 1994.
42. Oswald, I. P., R. T. Gazzinelli, A. Sher, and S. L. James. Il-10 synergises with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148: 3578-3582, 1992.
43. Pfeilschifter, J. Platelet-derived growth factor inhibits cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur. J. Pharmacol. 208: 339-341, 1991.
44. Pfeilschifter, J., and H. Schwarzenbach. Interleukin 1 and tumour necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett. 273: 185-187, 1990.
45. Pfeilschifter, J., and K. Vosbeck. Transforming growth factor b2 inhibits the interleukin-1b and tumour necrosis factor-a induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 175: 372-379, 1991.
46. Ramírez, F., D. J. Fowell, M. Puklavec, S. Simmonds, and D. Mason. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156: 2406-2412, 1996.
47. ω-hydroxyarginine to citrulline and nitrogen oxides and occurence in NO synthases of a sequence very similar to the heme-binding sequence in P450s. Biochem. Biophys. Res. Commun. 192: 53-60, 1993.
48. Rüegg, U. T., and A. Russell. A rapid and sensitive assay for arginase. Anal. Biochem. 102: 206-212, 1980.
49. Russell, A. S., and U. T. Ruegg. Arginase production by peritoneal macrophages: a new assay. J. Immunol. Methods 32: 375-382, 1980.
50. Saura, M., R. Martïnez-Dalmau, A. Minty, D. Pérez-Sala, and S. Lamas. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem. J. 313: 641-646, 1996.
51. Shearer, J. D., J. R. Richards, C. D. Mills, and M. D. Caldwell. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E181-E190, 1997.
52. Sonoki, T., A. Nagasaki, T. Gotoh, M. Takiguchi, M. Takeya, H. Matsuzaki, and M. Mori. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272: 3689-3693, 1997.
53. Spector, E. B., S. C. H. Rice, and S. D. Cederbaum. Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients. Pediatr. Res. 17: 941-944, 1983.
54. ω-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266: 6259-6263, 1991.
55. Tam, F. W. K., J. Smith, A. M. Karkar, C. D. Pusey, and A. J. Rees. Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor. Kidney Int. 52: 1224-1231, 1997.
56. Vockley, J. G., C. P. Jenkinson, H. Shukla, R. M. Kern, W. W. Grody, and S. D. Cederbaum. Cloning and characterisation of the human type II arginase gene. Genomics 38: 118-123, 1996.
57. Wang, W. W., C. P. Jenkinson, J. M. Griscavage, R. M. Kern, N. S. Arabolos, R. E. Byrns, S. D. Cederbaum, and L. J. Ignarro. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210: 1009-1016, 1995.